Insights in resistant diabetic macular oedema
5 August 2022
| Sofia Rokerya
|
Retina / Uvea / Vitreous
This article gives a bird’s eye review of the different modalities for the treatment of diabetic macular oedema (DME). The debut of anti-VEGFs has brought a paradigm shift in DME management. This treatment has now become a major breakthrough in...
Effect of syringe-filling technique and risk for endophthalmitis after intravitreal injection of anti-VEGF agents
2 August 2022
| Sofia Rokerya
|
Retina / Uvea / Vitreous
|
Aflibercept, Anti-vascular endothelial growth factor, Bevacizumab, Endophthalmitis, Filling, Prefilled syringe, Ranibizumab, Syringe
In this retrospective study the authors compare the risk for post-injection endophthalmitis between different anti-vascular endothelial growth factor (VEGF) agents and syringe preparation technique. This multicentre study included 197,402 injections. The drugs included in this study were three Anti-VEGF agents...
Morphological and functional outcome after subthreshold laser coagulation with a frequency-doubled Nd:YAG laser
2 August 2022
| Sofia Rokerya
|
Retina / Uvea / Vitreous
|
Central serous chorioretinopathy, Retinal imaging, Retinal laser coagulation
Central serous chorioretinopathy; Retinal imaging; Retinal laser coagulation
Clinical features and mortality of endogenous panophthalmitis in China
1 June 2022
| Su Young
|
Retina / Uvea / Vitreous
|
Endogenous endophthalmitis, Endogenous panophthalmitis, Interdisciplinary cooperation, Klebsiella pneumoniae, Pyogenic liver abscess
This longitudinal cohort study aimed to report the clinical features, treatment strategy, and mortality of 15 consecutive patients (16 eyes) with endogenous panophthalmitis (EP) at a tertiary medical centre of the largest eye centre in Northern China. Mean age was...
Evaluation of fluocinolone acetonide in the management of BRC
1 June 2022
| Jonathan Chan
|
Retina / Uvea / Vitreous
This is a single-centre, retrospective, intervention study of 15 eyes of birdshot retinochoroiditis (BRC) patients who received Iluvein, with a mean follow-up period of 31 months. Five eyes had previously received dexamethasone intravitreal implant 0.7mg (Ozurdex). Fluorescein angiography (FA) showed...
Air tamponade in pars plana vitrectomy for primary rhegmatogenous retinal detachment repair
1 June 2022
| Sofia Rokerya
|
Retina / Uvea / Vitreous
|
Air tamponade, Multiple retinal tears, Pars plana vitrectomy, Retinal detachment surgery
The authors report a study aimed to establish the use of air as a tamponade agent for primary rhegmatogenous retinal detachment (RRD) treatment, regardless of the position or the number of retinal breaks. Two hundred and thirty-six eyes of 230...
Traumatic macular holes: reconstructive changes in foveal microstructures and visual predictor analysis, following surgical repair
5 April 2022
| Sofia Rokerya
|
Retina / Uvea / Vitreous
The purpose of this paper was to investigate the reconstructive changes in foveal microstructures postoperatively and analyse the visual predictors in eyes with surgically closed traumatic macular holes (TMHs). This retrospective study analysed the data collected from 71 eyes of...
Foveal displacement after macular hole surgery
5 April 2022
| Kurt Spiteri Cornish
|
Retina / Uvea / Vitreous
|
Foveal displacement, internal limiting membrane peeling, metamorphopsia, papillofoveal distance, temporal inverted internal limiting membrane flap
Previous studies show that internal limiting membrane (ILM) peeling during macular hole surgery is associated with retinal shrinkage (microtubule depolymerization of the axons of the inner retina) and nasal shift of the fovea. A temporal inverted ILM flap technique was...
Detecting apoptosis in retinal cells
1 February 2022
| Sofia Rokerya
|
Retina / Uvea / Vitreous
|
Apoptosis, Glaucoma, Imaging, Neurodegeneration, Retina
This is a review paper in which the authors summarise the transitioning of techniques detecting apoptosis from bench to bedside, along with the future possibilities they encase. Detection of Apoptosis in Retinal Cells (DARC) technology can be used as a...
Occult central retinal artery occlusion
1 February 2022
| Kurt Spiteri Cornish
|
Retina / Uvea / Vitreous
|
CRAO, Central retinal artery occlusion, OCT, RAO, optical coherence tomography, retinal artery occlusion, spectral-domain optical coherence tomography
Central retinal artery occlusion (CRAO) is a sight-threatening condition resulting from occlusion of the central retinal artery and hypoperfusion of the inner retina. Early on, fundal examination may be normal. The authors present a retrospective case series of 11 patients...
Inflammation and microvascular changes in diabetic retinopathy
1 February 2022
| Kurt Spiteri Cornish
|
Retina / Uvea / Vitreous
|
Aqueous flare, diabetes mellitus, diabetic retinal neuropathy, diabetic retinopathy, intraocular inflammation, neuroinflammation
Studies have shown that neurodegeneration and inflammation in the retina start early in diabetic retinopathy (DR) and can be present before the latter is clinically evident. The aim of this retrospective review of 99 diabetic patients was to evaluate retinal...
Incidence and outcomes of endophthalmitis with in-house compounded intravitreal bevacizumab injections
1 December 2021
| Su Young
|
Retina / Uvea / Vitreous
|
IVI, In-house compounded, bevacizumab, compounding pharmacy, endophthalmitis
This multicentre study examining a five-year period from 2014 to 2018 evaluated the incidence rate and outcomes of endophthalmitis after intravitreal injection of in-house compounded bevacizumab. In-house compounded syringes were prepared in compounding pharmacy using sterile standard operating guidelines. All...
